These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28751497)

  • 1. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.
    Nikhil K; Shah K
    J Cell Sci; 2017 Sep; 130(18):3023-3039. PubMed ID: 28751497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction.
    Sun KH; de Pablo Y; Vincent F; Shah K
    J Neurochem; 2008 Oct; 107(1):265-78. PubMed ID: 18691386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.
    Nikhil K; Viccaro K; Shah K
    Mol Neurobiol; 2019 Feb; 56(2):1366-1390. PubMed ID: 29948941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
    Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
    Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.
    Chang KH; de Pablo Y; Lee HP; Lee HG; Smith MA; Shah K
    J Neurochem; 2010 Jun; 113(5):1221-9. PubMed ID: 20345761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Lopes JP; Oliveira CR; Agostinho P
    Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
    Orellana DI; Quintanilla RA; Maccioni RB
    Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.
    Chang KH; Multani PS; Sun KH; Vincent F; de Pablo Y; Ghosh S; Gupta R; Lee HP; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2011 May; 22(9):1452-62. PubMed ID: 21389115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
    Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
    J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.
    Sun KH; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2009 Nov; 20(21):4611-9. PubMed ID: 19776350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo.
    Reinhardt L; Kordes S; Reinhardt P; Glatza M; Baumann M; Drexler HCA; Menninger S; Zischinsky G; Eickhoff J; Fröb C; Bhattarai P; Arulmozhivarman G; Marrone L; Janosch A; Adachi K; Stehling M; Anderson EN; Abo-Rady M; Bickle M; Pandey UB; Reimer MM; Kizil C; Schöler HR; Nussbaumer P; Klebl B; Sterneckert JL
    Stem Cell Reports; 2019 Mar; 12(3):502-517. PubMed ID: 30773488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.
    Tang X; Wang X; Gong X; Tong M; Park D; Xia Z; Mao Z
    J Neurosci; 2005 May; 25(19):4823-34. PubMed ID: 15888658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
    Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
    J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
    Chang KH; Vincent F; Shah K
    J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
    Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
    Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK5-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.
    Ogara MF; Belluscio LM; de la Fuente V; Berardino BG; Sonzogni SV; Byk L; Marazita M; Cánepa ET
    Biochim Biophys Acta; 2014 Jul; 1843(7):1309-24. PubMed ID: 24703879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling Potential Neurotoxic Mechansisms: Pb-Induced Activation of CDK5-p25 Signaling Axis in Alzheimer's Disease Development, Emphasizing CDK5 Inhibition and Formation of Toxic p25 Species.
    Lokesh M; Bandaru LJM; Rajanna A; Rao JS; Challa S
    Mol Neurobiol; 2024 May; 61(5):3090-3103. PubMed ID: 37968421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.